Kiadis Pharma announces abstracts and presentations for the 60th American Society of Hematology (ASH) Annual Meeting

Amsterdam, The Netherlands, November 7, 2018 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces two data presentations at the 60th American Society of Hematology (ASH) Annual Meeting. The event will be held December 1-4, 2018, at the San Diego Convention Center in San Diego, CA.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...